The content on this site is intended for healthcare professionals only
Prof Richard Sullivan - King's College London, speaking at the ECCO 15 - ESMO 34 congress in Berlin, calling for new cancer research priorities to correct imbalance that leaves important questions neglected.
Daratumumab, bortezomib/thalidomide/dexamethasone (D-VTd) and DARA maintenance shows benefit in transplant-eligible NDMM
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Use of bispecifics and CAR T cells in South America
Revolutionising myeloma treatment through immune profiling
Guiding transplant decisions in multiple myeloma with MRD
Revolutionising multiple myeloma treatment with CAR T-Cell therapies
The case for global gender-neutral HPV vaccination
Cooperative training for medical staff in Côte d'Ivoire: The national radiotherapy and medical oncology center project
Laser oncosurgery - A new perspective in treating cancer
